Published: April 14, 2025
The Commerce Department has begun a Section 232 investigation into the national security effects of the U.S. importing pharmaceuticals and their starting materials.
Read MoreLearn how to use the site
Watch Tutorial
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Cras fermentum ultrices varius. Vivamus cursus turpis sed finibus ultricies. Nullam id mauris accumsan tellus facilisis eleifend. Vivamus sed lorem sit amet nisi gravida maximus. Suspendisse consequat auctor lacus et laoreet. In hac habitasse platea dictumst. Praesent ultricies elit sagittis felis lobortis, nec aliquam arcu gravida.
